I don't think that's entirely right. I just commented on the board that BB was banned and all my posts were removed. There's been a total of seven banned posters over the last week.
Some of you have commented on the number of IHUB posters that have been banned over the last week. While this is pure speculation, I think there's an explanation for what has been going on. As most everyone knows, Amarin is one of the most polarized stocks in biotech and possibly the overall market. AMRN followers are activists and have generally used the IHUB forum to post their angst toward the FDA over the SPA, adcomm and the regulatory process surrounding NCE. Recently, there was correspondence submitted to members of the US Senate prior to Janet Woodcock's appearance before a committe/sub-committee. Several members on IHUB used the board to colloborate and draft a letter . In addition, contact information for several senators was also exchanged and phone follow up was also made (as I understand it) As it turned out, Woodcock's appearance didn't address any of the issues outlined in the letter. It was merely a dog-n-pony appearance. I do believe the correspondence sent by AMRN followers rubbed someone the wrong way and some of these posters (BioBill and others) were banned by the IHUB administrator.
Such lipid disorders are extremely rare??????? CVD is the #1 kiiler in the US. Listen ...... tired of your rambling on. Go ahead and take your OTC fish oil and forego blood work to cut cost if that's your argument. I've been taking V since Feb 2012 and will continue to pay $9 per month through 2015. After that I pay Tier II which would be roughly $30 per month.
The facts going forward are this. AMRN share price will continue to move upward as we move in 2H 2015 in anticipation of RI. Some say AMRN will be close to $5 by EOY. The company may or may not get NCE designation - we will soon know. If you invest in AMRN, you will probably then be able to afford a couple of Dr. visits by the EOY and possibly have some cash left over for bloodwork. You also need to research lipidiology. It appears Stonepine and other have already. Also, good luck with all your OTC products - including fish oil.
You do need a prescription to get pharma grade EPA for high trigs or choose to take it for the benefit of inflammation reduction. Many of these people also have other lipid disorders in addition to elevated trigs and require the care of a physician. In fact, a new speciality has emerged in the treatment of treating CV disease called lipidology. I currently pay $9 per month for Vascepa with the co-pay program.. What's your price???????????
Seriously dude, you need to do your homework. Research the cost, profile and market for these drugs. There is so much stupid, uneducated stuff posted on this board. Yahoo needs to shut her down!!!!!!!!!!!!!!!!!!!!!!
It will depend on how Judge Moss decides this case. If AMRN get a NCE positive retro to July 2012, then we'll probably see $3.00 - $3.25. If it dates from decision then $4.00 is possible.. If he rules in favor of FDA, we'll probably drop below $2 for awhile.
Said this before on this board - people with high intelligence talk about ideas. People with average intelligence talk about events. People with low intelligence talk about other people. If fact, when you talk about others, you can't even get your information correct.
I did a little research on this topic and you can Google it as well. According to some in the judicial system, an opinion can be rendered within 60 days and in some cases as long as 90 days. I also talked with a couple of local attorneys and they provided the same general feedback. The duration - quick vs short - doesn't suggest the outcome will favor either the plaintiff or defendant. If fact, a case involving this type of complexity requires legal research and writing of opinion. I think Judge Randolph Moss knows the precedence involved in this case and consequences moving forward.
I also did a bit of history search on Judge Moss. I was primarily attempting to look at his judicial record. I discovered he was actually appointed by President Obama in October 2014 with a JD from Yale. He was confirmed by the US Senate by a 55-45 vote that basically ran down party lines. This has been a little concerned however many on the bench don't necessarily vote based along party lines - just look at the Supreme Court. I also looked at the Waxman-Hatch act which much of this case is centered around. It was somewhat interesting that the bill was sponsored by a democrat and republican - so it shows that it was reached by cooperation across the isle. The key to this outcome - I believe - centers around the intent or meaning of the Waxman-Hatch vs. how the FDA has re-interpreted it. Specifically, will Judge Moss view NCE as a mixture undefined or moiety broken down?
You guyz really pound the board but overall as ignorant as a 1st grader in your approach. I made roughly $100,000 on DNDN. I suppose with your mother's allowance and the $25 per day in YMB spamming, you may see that of of money over the course of your lifetime.
I have seen your past posts and have basically refrained from making comments due to the basic ignorance and understanding you demonstrate. You contribute absolutely nothing of consequence to this board and demonstrate zero intellect with your writing skills. However your "pathetic" post is an accurate reflection of you. AMRN's recent performance is as follows:
1 mo -14.67%
3 mo - 138%
YTD - 147%
6 mo - 131%
1 Yr - 54%
Your negativity indicates a lack of knowledge. I would take that performance of any equity in my portfolio. I'm awaiting your pathetic response.
You're clueless as to what's going on here. The was a condition of initial private placement back in early March 2015. Amarin board member James Healy is a partner at Sofinnova. Sofinnova wanted back in to AMRN for RI. This is smart money at play getting a contractual price.
This thread has been discussed a zillion times! Vascepa like hundreds of other medications is sold off-label. Lovaza was a billion dollar a year drug at its peak. Do you think it was sold to people with trigs 500?
So would it then be fair to conclude that April 2015 results of Cherry would be consistent with 4 grams of EPA dosed over a similar period in the US? If these results show promise, the FDA will have to take notice much the same way they did with ACCORD, THRIVE and some of the the niacin studies they cited failed.
BTW, why the thumbs down from other posters?????